Why Is Iterum Therapeutics (ITRM) Stock Up 73% Today?
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Iterum Therapeutics (ITRM) stock is taking off on Monday as investors react to news of a clinical trial agreement with the FDA.
The post Why Is Iterum Therapeutics (ITRM) Stock Up 73% Today? appeared first on InvestorPlace.
More From InvestorPlace